CMS launched the Part D Enhanced Medication Therapy Management model Jan. 1 in five Part D regions nationwide to test the use of innovative medication therapy management programs to improve care ...
On Friday, the fledgling field of psychedelic medicine suffered a major setback. The FDA declined to approve MDMA-assisted therapy for PTSD, instead asking the drugmaker Lykos Therapeutics to conduct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results